Dr. Christopher Bligh Komanski, MD

Dr. Komanski practices at Asheville Eye Surgery Center (Medical Park Dr) in Asheville, North Carolina.

Dr. Komanski's NPI, 1558781856, was assigned on April 24, 2014. Dr. Komanski holds North Carolina license 201902519.

Dr. Komanski's primary practice is Asheville Eye Surgery Center (Medical Park Dr), at 8b Medical Park Drive, Asheville, NC 28803. The practice phone is (828) 210-2020. Dr. Komanski also practices at Asheville Eye Associates PLLC, 8 Medical Park Dr, Asheville, NC 28803.

Dr. Komanski's primary practice is Asheville Eye Surgery Center (Medical Park Dr) in Asheville, North Carolina. Dr. Komanski is also affiliated with Mission Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Komanski to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Komanski practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Komanski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Komanski's licenses on file in 2 states: North Carolina and Utah.

CMS data shows 66,807 Medicare services from Dr. Komanski across 17 procedure codes in 2024, for 1,401 Medicare patients. Medicare paid $2,915,031 for them.

CMS counts 1,401 Medicare patients who saw Dr. Komanski in 2024. The largest group is 75 to 84, with 564 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Komanski's median patient age at 77, with 60% women.

In 2024, Dr. Komanski wrote 550 Medicare Part D claims for 152 patients. 62% of them were for generic drugs. CMS names the drug for 506 of them, across 10 drugs with 11 or more claims each, at $19,527 in total drug cost. In 2023, CMS named 304 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Komanski for performance year 2024, reported through an alternative payment model (APM). Dr. Komanski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of cataract surgery by Dr. Komanski, more than 37% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Komanski in 2017. Dr. Komanski's most frequent co-authors are Paul S. Bernstein, Craig Michael Greven, MD and Addisu Mesfin, MD.

CMS Open Payments shows 157 general payments to Dr. Komanski from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Genentech, Inc. paid the most, $104,780.